Neeha Zaidi

Bill Nelson.

So it's Bill Nelson, Director of the Sidney Kimmel Comprehensive Cancer Center, and today we get to catch up with one of our pancreatic cancer and immunology immunotherapy experts, uh, Neeha Zaidi.

And she's done a whole bunch of work, which we're gonna get to, because we want to hear about it from her, related to using vaccines, so hopefully in a posture that might ultimately prevent people at high risk for pancreatic cancer from getting the disease at all, which would be, you know, clearly wonderful.

But let's start with pancreatic cancer itself.

There's still a lot more that we have to do in terms of determining whether the immune cells are actually getting to the pre-cancer, what they look like.

And so while these interception studies are super exciting, I think now we really have to think, how do we move this forward? How do we scale it up?

So we've been catching up with Neeha Zaidi, a pancreatic cancer expert and immunologist, immunotherapy expert, and talking about what the future of pancreatic cancer might look like, figuring out who's at risk with the disease, maybe some people at higher risk than others, using imaging to figure out, hopefully, whether they have some precursor lesions or not, and then intervening perhaps before or after you detect these precursor lesions with immunotherapy, maybe other kinds of treatments to head off pancreas cancer altogether.

What a wonderful world that would be.